World Federation of Hemophilia /LinkedIn
Feb 4, 2026, 17:28
Join the World Federation of Hemophilia at EAHAD 2026
World Federation of Hemophilia – WFH shared a post on LinkedIn:
“Join the World Federation of Hemophilia at EAHAD 2026 and connect with our work on gene therapy, gene editing, von Willebrand disease, and shared decision-making in Bleeding Disorders.
Oral presentation
WFH, EAHAD, and EHC: Best practice recommendations for implementing shared decision-making in hemophilia
Friday, February 6 | 8:30 a.m. | Session OR10
Posters on display (Level 0)
- The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025 (PO067)
- Enhancing Understanding of Gene Editing in Hemophilia: A New WFH Initiative (PO176)
- Global disparities in von Willebrand disease diagnosis and management: an analysis using the WFH World Bleeding Disorders Registry (PO228)
February 4 – 6, 2026 | Poster area, Level 0
We invite you to stop by and learn more.”
More posts about World Federation of Hemophilia.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice